Page last updated: 2024-08-17

n-vinyl-2-pyrrolidinone and Coronary Restenosis

n-vinyl-2-pyrrolidinone has been researched along with Coronary Restenosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antunes, E; Krieger, MH; Lemos, ME; Marcondes, S; Shishido, SM; Sorragi, Cde L1

Other Studies

1 other study(ies) available for n-vinyl-2-pyrrolidinone and Coronary Restenosis

ArticleYear
In vitro evaluation of the safe margin, antithrombotic and antiproliferative actions for the treatment of restenosis: Nitric oxide donor and polymers.
    Cell biochemistry and function, 2011, Volume: 29, Issue:3

    Topics: Animals; BALB 3T3 Cells; Cell Proliferation; Coronary Restenosis; Drug Evaluation, Preclinical; Drug-Eluting Stents; Drug-Related Side Effects and Adverse Reactions; Fibrinolytic Agents; Humans; Mice; Myocytes, Smooth Muscle; Nitric Oxide; Nitric Oxide Donors; Platelet Adhesiveness; Platelet Aggregation; Polyvinyl Alcohol; Povidone; Rabbits; S-Nitrosoglutathione

2011